5Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725.
6Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483.
7Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117.
8Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105.
9Lzumi N, Enomoto N, Uchihara M, et al. Hepaticiron contents and response to interfero-a in patients with chronic hepatitis C [ J]. Dig Dis Sci, 1996,41(5) :989-994.
10Bacon BR,Farahvash MJ,Janney CG, et al. Nonalcoholic steatohepatitis: an expanded clinical entity[ J ]. Gastroenterology, 1994,107 (4):1103-1109.
8Xin Ying, Yan Jiang, Yafang Qian, et al. Association be- tween Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults [ J ]. Irma J Public Health, 2012,41 ( 1 ) :45.
9International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [ J ]. Berlin, 2005: 14.
10FAN J G,ZHU J,L1 X J,et al ,Prevalence of and risk fac- tors for fatty liver in a general population of Shanghai ,China[ J]. J Hepatol,2005,43 ( 3 ) :508.
